title: Minimum alveolar concentration (MAC) of xenon with sevoflurane in humans.
abstract: BACKGROUND
  Although more than 30 yr ago the minimum alveolar concentration (MAC) of xenon was determined to be 71%, that previous study had technological limitations, and no other studies have confirmed the MAC value of xenon since. The current study was designed to confirm the MAC value of xenon in adult surgical patients using more modern techniques.
  
  
  METHODS
  Sixty patients were anesthetized with sevoflurane with or without xenon. They were randomly allocated to one of four groups; patients in group 1 received no xenon, whereas those in groups 2, 3, and 4 received end-tidal concentrations of 20, 40, and 60%, respectively (n = 15 each group). Target end-tidal sevoflurane concentrations were chosen using the "up-and-down" method in each group. After steady state sevoflurane and xenon concentrations were maintained for at least 15 min, each patient was monitored for a somatic response at surgical incision. Somatic response was defined as any purposeful bodily movement. The MAC of sevoflurane and its reduction by xenon was evaluated using the multiple independent variable logistic regression model.
  
  
  RESULTS
  The interaction coefficient of the multiple variable logistic regression was not significantly different from zero (P = 0.143). The MAC of xenon calculated as xenon concentration that would reduce MAC of sevoflurane to 0% was 63.1%.
  
  
  CONCLUSIONS
  The authors could not determine whether interaction in blocking somatic responses in 50% of patients is additive. The MAC of xenon is in the range of the values that were predicted in a previous study.
authors.affiliation: Department of Anesthesiology, Teikyo University School of Medicine Ichihara Hospital, Chiba, Japan. ynakata@med.teikyo-u.ac.jp
authors.forename: Y
authors.initials: Y
authors.lastname: Nakata
authors.forename: T
authors.initials: T
authors.lastname: Goto
authors.forename: Y
authors.initials: Y
authors.lastname: Ishiguro
authors.forename: K
authors.initials: K
authors.lastname: Terui
authors.forename: H
authors.initials: H
authors.lastname: Kawakami
authors.forename: M
authors.initials: M
authors.lastname: Santo
authors.forename: Y
authors.initials: Y
authors.lastname: Niimi
authors.forename: S
authors.initials: S
authors.lastname: Morita
mesh_terms: D000328:Adult; D018685:Anesthetics, Inhalation / Q000493:pharmacokinetics*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008875:Middle Aged; D011650:Pulmonary Alveoli / Q000378:metabolism*; D012044:Regression Analysis; D000077149:Sevoflurane; D014978:Xenon / Q000008:administration & dosage / Q000493:pharmacokinetics*
chemical_list: D018685:Anesthetics, Inhalation; D008738:Methyl Ethers; D000077149:Sevoflurane; D014978:Xenon